Full text
Earnings transcript
Read the complete earnings call transcript.
SCL
Stepan Company
$49.97
-0.04
(-0.08%)
| Exchange: | NYSE |
| Market Cap: | 1.131B |
| Shares Outstanding: | 22.917M |
About The Company
| Sector: | Basic Materials | |||||
| Industry: | Chemicals – Specialty | |||||
| CEO: | Luis E. Rojo | |||||
| Full Time Employees: | 2396 | |||||
| Address: |
| |||||
| Website: | https://www.stepan.com |
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. It serves in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 2,325,768 | 2,180,274 | 2,332,114 |
| Gross Profit | 277,598 | 272,214 | 269,888 |
| EBITDA | 169,675 | 192,101 | 208,019 |
| Operating Income | 58,613 | 70,480 | 68,899 |
| Net Income | 40,204 | 50,370 | 46,895 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 2,363,354 | 2,304,648 | 2,357,702 |
| Total Liabilities | 1,146,864 | 1,134,714 | 1,113,692 |
| Total Stockholders Equity | 1,216,490 | 1,169,934 | 1,244,010 |
| Total Debt | 712,172 | 682,831 | 340,975 |
| Cash and Cash Equivalents | 129,823 | 99,665 | 0 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 174,876 | 162,053 | 147,882 |
| Capital Expenditure | -260,335 | -122,776 | 0 |
| Free Cash Flow | -85,459 | 39,277 | 147,882 |
| Net Income | 40,204 | 50,370 | 46,895 |
| Net Change in Cash | -43,927 | -30,158 | 33,023 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 2,593,961.012 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 2,708,438.987 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 2,651,200 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 244,678.275 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 255,476.538 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 250,077.407 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 161,135.892 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 168,247.221 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 164,691.556 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 0 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 0 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 0 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid Financial Performance: Stepan Company reported a 9% growth in adjusted EBITDA for Q3 2025, as highlighted in the earnings call transcript, reflecting strong operational efficiency and profitability improvements despite market challenges.
- Positive Revenue Trends: Historical income statement data indicates consistent revenue generation, supported by diversified product categories as seen in revenue product segments, which likely contributes to financial stability.
- Strong Liquidity Position: Balance sheet metrics, including cash and cash equivalents and a favorable current ratio (TTM), suggest the company maintains adequate liquidity to meet short-term obligations, providing a buffer against operational risks.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates SCL intrinsic value between $25.20 – $53.85 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about SCL valuation
Is Stepan Company (SCL) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Stepan Company (SCL) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is SCL a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SCL trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is SCL’s P/E ratio?
You can see SCL’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for SCL?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is SCL a good long-term investment?
Whether SCL fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
SCL
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-0.08
Trading Metrics:
| Open: | 49.5 | Previous Close: | 50.01 | |
| Day Low: | 49.18 | Day High: | 50.27 | |
| Year Low: | 41.82 | Year High: | 68 | |
| Price Avg 50: | 54.15 | Price Avg 200: | 50.55 | |
| Volume: | 103174 | Average Volume: | 175614 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeSCL full analysis
Welcome to MARKETSNAP’s SWOT analysis for Stepan Company, also known by its ticker SCL. If you’re not familiar with Stepan Company, let me give you the quick rundown. This is a specialty chemical manufacturer operating in the Materials sector, specifically within the chemicals industry. They produce a wide range of surfactants, polymers, and specialty ingredients used in everything from personal care products to industrial applications. With a global footprint and a solid workforce, they’ve carved out a niche in a…
